107 filings
8-K
TVGN
Tevogen Bio Holdings Inc.
2 May 24
Changes in Registrant's Certifying Accountant
5:25pm
8-K/A
TVGN
Tevogen Bio Holdings Inc.
26 Apr 24
Financial Statements and Exhibits
9:22pm
10-K
2023 FY
TVGN
Tevogen Bio Holdings Inc.
Annual report
26 Apr 24
9:21pm
8-K
TVGN
Tevogen Bio Holdings Inc.
26 Apr 24
Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments
8:30am
8-K/A
TVGN
Tevogen Bio Holdings Inc.
10 Apr 24
Entry into a Material Definitive Agreement
5:06pm
NT 10-K
t6jg t4ug
2 Apr 24
Notice of late annual filing
4:35pm
8-K
use7fizhuj8h
2 Apr 24
Entry into a Material Definitive Agreement
9:22am
8-K
6813y3bv 4w5lnsa
21 Mar 24
Amendments to Articles of Incorporation or Bylaws
5:07pm
8-K
bjpgb2hiwhu1tfsx tx5
21 Feb 24
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
4:30pm
8-K/A
t8tmxjt76bt8w yusx
20 Feb 24
Entry into a Material Definitive Agreement
8:57am
CERT
pik6lxk
14 Feb 24
Certification of approval for exchange listing
6:05pm
8-A12B
q1mdux1 as
14 Feb 24
Registration of securities on exchange
5:20pm
8-K
1rxxca1bvo2 hc78p
14 Feb 24
Entry into a Material Definitive Agreement
5:18pm
25-NSE
1qvcn78e z8k9g
14 Feb 24
Exchange delisting
4:06pm
425
y62c z84jm
1 Feb 24
Business combination disclosure
8:27am
8-K
zc25gp1w
1 Feb 24
Semper Paratus Acquisition Corporation’s Shareholders Approve Business Combination with Tevogen Bio
8:25am
425
4br3kmifra lbchpxg
31 Jan 24
Business combination disclosure
8:27am
424B3
7x8yc faim0cbjo
24 Jan 24
Prospectus supplement
4:37pm
425
89w9 m656zwusug7
24 Jan 24
Business combination disclosure
4:16pm
8-K
qoff9jcdu67akmol
24 Jan 24
Semper Paratus Acquisition Corporation Announces Anticipated Listing of Tevogen Bio Holdings Inc. on Nasdaq
4:15pm